1y return+13.8%S&P 500 +20.9%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since December 31, 2023: $216 against $157 in the S&P 500.2
a16z Capital Management, L.L.C.S&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| SPCXSpace Exploration Techn Corp | $12.8B | 90.0% | New |
| NAVNNavan Inc | $645.4M | 4.5% | |
| RVMDRevolution Medicines Inc | $172.5M | 1.2% | |
| METAMeta Platforms Inc | $119.7M | 0.8% | |
| FIGFigma Inc | $108.2M | 0.8% | −62.6% |
| BIOABioage Labs Inc | $79.2M | 0.6% | |
| XYZBlock Inc | $77.3M | 0.5% | |
| ERASErasca Inc | $52.4M | 0.4% | |
| MAZEMaze Therapeutics Inc | $50.8M | 0.4% | |
| Damora Therapeutics IncCUSIP 36322Q206 | $32.2M | 0.2% | |
| OMDAOmada Health Inc | $25.3M | 0.2% | −50.0% |
| NAUTNautilus Biotechnology Inc | $16.9M | 0.1% | −48.7% |
| RBLXRoblox Corp | $14.9M | 0.1% | New |
| AKTSAktis Oncology Inc | $13.4M | 0.1% | |
| CAMPCamp4 Therapeutics Corp | $9.3M | 0.1% | |
| BTGOBitgo Holdings Inc | $3.5M | 0.0% | |
| KLRAKailera Therapeutics Inc | $3.1M | 0.0% | New |
| DNAGinkgo Bioworks Holdings Inc | $1.1M | 0.0% | |
| IPSTIp Strategy Holdings Inc | $9,722 | 0.0% | New |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| RVMDRevolution Medicines Inc | December 31, 2023 | +553.0% | $172.5M |
| MAZEMaze Therapeutics Inc | March 31, 2025 | +171.0% | $50.8M |
| AKTSAktis Oncology Inc | March 31, 2026 | +80.2% | $13.4M |
| NAVNNavan Inc | December 31, 2025 | +33.9% | $645.4M |
| DNAGinkgo Bioworks Holdings Inc | September 30, 2024 | +21.6% | $1.1M |
| OMDAOmada Health Inc | June 30, 2025 | +19.9% | $25.3M |
| Damora Therapeutics IncCUSIP 36322Q206 | March 31, 2026 | +0.4% | $32.2M |
| XYZBlock Inc | December 31, 2023 | −1.7% | $77.3M |
| CAMPCamp4 Therapeutics Corp | December 31, 2024 | −16.3% | $9.3M |
| METAMeta Platforms Inc | September 30, 2025 | −23.3% | $119.7M |
Sold off last quarter
- Ip Strategy Holdings IncCUSIP 42727R203 was $22K
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +26.3% | +14.8% |
| March 31, 2026 | −23.1% | −4.6% |
| December 31, 2025 | −8.4% | +2.4% |
| September 30, 2025 | +27.9% | +7.8% |
| June 30, 2025 | +15.5% | +10.5% |
| March 31, 2025 | −8.5% | −4.6% |
| December 31, 2024 | +21.7% | +2.1% |
| September 30, 2024 | +17.6% | +5.4% |
| June 30, 2024 | −8.4% | +4.0% |
| March 31, 2024 | +37.0% | +10.0% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: a16z Capital Management, L.L.C. Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1540358&type=13F-HR&dateb=&owner=include&count=40CIK 1540358
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1540358/000154035826000010/Filed August 14, 2026 · accession 0001540358-26-000010